CALR and cancer: Indeed, we found that CRT binding to cancer cells was markedly enhanced after neuraminidase treatment and was specific to the asialoglycans (Fig. 5a–d); and that such treatment significantly promoted phagocytosis of a wide range of human cancer cells by either human or mouse macrophages (Fig. 5e, f and Supplementary Fig. 5a–c).